419 related articles for article (PubMed ID: 35590145)
1. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.
Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM
Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145
[TBL] [Abstract][Full Text] [Related]
2. BCG vaccination strategies against tuberculosis: updates and perspectives.
Qu M; Zhou X; Li H
Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
[TBL] [Abstract][Full Text] [Related]
3. An overview of the BCG vaccine and its future scope.
Khandelia P; Yadav S; Singh P
Indian J Tuberc; 2023; 70 Suppl 1():S14-S23. PubMed ID: 38110255
[TBL] [Abstract][Full Text] [Related]
4. A review of the BCG vaccine and other approaches toward tuberculosis eradication.
Cho T; Khatchadourian C; Nguyen H; Dara Y; Jung S; Venketaraman V
Hum Vaccin Immunother; 2021 Aug; 17(8):2454-2470. PubMed ID: 33769193
[TBL] [Abstract][Full Text] [Related]
5. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
[TBL] [Abstract][Full Text] [Related]
6. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines.
Foster M; Hill PC; Setiabudiawan TP; Koeken VACM; Alisjahbana B; van Crevel R
Immunol Rev; 2021 May; 301(1):122-144. PubMed ID: 33709421
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin (BCG) Revaccination and Protection Against Tuberculosis: A Systematic Review.
Lawrence A
Cureus; 2024 Mar; 16(3):e56643. PubMed ID: 38646352
[TBL] [Abstract][Full Text] [Related]
8. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
10. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
[TBL] [Abstract][Full Text] [Related]
11. Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination.
Kurtz SL; Mittereder LR; Lehman CC; Khan H; Gould VA; Elkins KL
Infect Immun; 2023 Jul; 91(7):e0016823. PubMed ID: 37338410
[TBL] [Abstract][Full Text] [Related]
12. Current challenges and opportunities for bacillus Calmette-Guérin replacement vaccine candidates.
Méndez-Samperio P
Scand J Immunol; 2019 Oct; 90(4):e12772. PubMed ID: 31055842
[TBL] [Abstract][Full Text] [Related]
13. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
Abebe F
Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
[TBL] [Abstract][Full Text] [Related]
14. Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
Guerra-Maupome M; Vang DX; McGill JL
PLoS One; 2019; 14(2):e0212751. PubMed ID: 30794653
[TBL] [Abstract][Full Text] [Related]
15. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
Moliva JI; Turner J; Torrelles JB
Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
[TBL] [Abstract][Full Text] [Related]
16. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
[TBL] [Abstract][Full Text] [Related]
17. A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium tuberculosis.
O'Hara JM; Wakabayashi S; Siddiqi N; Cheung E; Babunovic GH; Thompson CM; Lu YJ; Rubin EJ; Malley R; Zhang F
mBio; 2023 Feb; 14(1):e0361122. PubMed ID: 36749098
[TBL] [Abstract][Full Text] [Related]
18. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
19. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.
Komine-Aizawa S; Yamazaki T; Yamazaki T; Hattori S; Miyamoto Y; Yamamoto N; Haga S; Sugitani M; Honda M; Hayakawa S; Yamamoto S
Clin Vaccine Immunol; 2010 Oct; 17(10):1500-6. PubMed ID: 20685935
[TBL] [Abstract][Full Text] [Related]
20. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
